Editorial
doi: 10.1681/ASN.2009111127.
Epub 2009 Dec 24.
Does TREAT give the boot to ESAs in the treatment of CKD anemia?
- PMID: 20035034
- DOI: 10.1681/ASN.2009111127
Item in Clipboard
Editorial
Does TREAT give the boot to ESAs in the treatment of CKD anemia?
J Am Soc Nephrol.
2010 Jan.
No abstract available
Similar articles
-
Against TREATing all patients alike: lessons from an FDA Advisory Committee Meeting.J Am Soc Nephrol. 2011 Jan;22(1):1-2. doi: 10.1681/ASN.2010111133. Epub 2010 Dec 16. J Am Soc Nephrol. 2011. PMID: 21164031 No abstract available.
-
Are there implications from the Trial to Reduce Cardiovascular Events with Aranesp Therapy study for anemia management in dialysis patients?Curr Opin Nephrol Hypertens. 2010 Nov;19(6):567-72. doi: 10.1097/MNH.0b013e32833c3cc7. Curr Opin Nephrol Hypertens. 2010. PMID: 20601876 Review.
-
Emerging drugs for treatment of anemia of chronic kidney disease.Expert Opin Emerg Drugs. 2013 Dec;18(4):421-9. doi: 10.1517/14728214.2013.836490. Epub 2013 Sep 16. Expert Opin Emerg Drugs. 2013. PMID: 24033253 Review.
-
Time to Reconsider Evidence for Anaemia Treatment (TREAT) = Essential Safety Arguments (ESA).Nephrol Dial Transplant. 2010 Jun;25(6):1734-7. doi: 10.1093/ndt/gfq099. Epub 2010 Mar 2. Nephrol Dial Transplant. 2010. PMID: 20200007 No abstract available.
-
Potential mechanisms of adverse outcomes in trials of anemia correction with erythropoietin in chronic kidney disease.Nephrol Dial Transplant. 2009 Apr;24(4):1082-8. doi: 10.1093/ndt/gfn601. Epub 2008 Nov 5. Nephrol Dial Transplant. 2009. PMID: 18987263 No abstract available.
Cited by
-
Diabetes, anemia and CKD: Why TREAT?Curr Diab Rep. 2010 Aug;10(4):291-6. doi: 10.1007/s11892-010-0123-5. Curr Diab Rep. 2010. PMID: 20544312 Review.
-
Efficiency of U.S. dialysis centers: an updated examination of facility characteristics that influence production of dialysis treatments.Health Serv Res. 2014 Jun;49(3):838-57. doi: 10.1111/1475-6773.12127. Epub 2013 Nov 18. Health Serv Res. 2014. PMID: 24237043 Free PMC article.
-
Longer-term outcomes of darbepoetin alfa versus epoetin alfa in patients with ESRD initiating hemodialysis: a quasi-experimental cohort study.Am J Kidney Dis. 2015 Jul;66(1):106-13. doi: 10.1053/j.ajkd.2015.02.339. Epub 2015 May 2. Am J Kidney Dis. 2015. PMID: 25943715 Free PMC article.
-
Intravenous iron in heart failure: beyond targeting anemia.Curr Heart Fail Rep. 2011 Mar;8(1):14-21. doi: 10.1007/s11897-010-0034-4. Curr Heart Fail Rep. 2011. PMID: 21057903 Review.
-
Prognostic significance of left ventricular hypertrophy observed at dialysis initiation depends on the pre-dialysis use of erythropoiesis-stimulating agents.Clin Exp Nephrol. 2013 Apr;17(2):294-303. doi: 10.1007/s10157-012-0705-4. Epub 2012 Oct 26. Clin Exp Nephrol. 2013. PMID: 23100176
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
